-
FDA approves new treatment for bacterial infections
NEW YORK The Food and Drug Administration has approved a new treatment for bacterial infections made by Forest Labs, Forest said.
The drug maker announced the approval of Teflaro (ceftaroline fosamil) for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection, also known as ABSSSI, caused by bacteria that include methicillin-resistant Staphylococcus aureaus.
-
Survey reveals lifestyle habits among diabetes patients
WOONSOCKET, R.I. CVS/pharmacy on Monday announced results of a survey examining various aspects of disease management and lifestyle for patients with diabetes. Of 3,242 respondents with diabetes, 32% reported they have been less vigilant about daily glucose testing due to cost, and as many as 24% of respondents said that cost has led them to be less conscientious about maintaining a proper diet.